Universe Pharmaceuticals Inc UPC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if UPC is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $2.18
- Day Range
- $2.19–2.40
- 52-Week Range
- $0.75–5.88
- Bid/Ask
- $2.40 / $2.49
- Market Cap
- $8.71 Mil
- Volume/Avg
- 52,850 / 92,687
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.27
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 225
- Website
- http://www.universe-pharmacy.com
Valuation
|
Metric
|
UPC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.22 |
Price/Sales | 0.27 |
Price/Cash Flow | — |
Price/Earnings
UPC
Financial Strength
|
Metric
|
UPC
|
|---|---|
Quick Ratio | 2.13 |
Current Ratio | 2.68 |
Interest Coverage | −23.55 |
Quick Ratio
UPC
Profitability
|
Metric
|
UPC
|
|---|---|
Return on Assets (Normalized) | −10.88% |
Return on Equity (Normalized) | −14.97% |
Return on Invested Capital (Normalized) | −13.27% |
Return on Assets
UPC
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Yxdbshfh | Wxcvc | $73.0 Bil | |
MKKGY
| Merck KGaA ADR | Pysrhqgt | Trnflty | $70.8 Bil | |
HLN
| Haleon PLC ADR | Ylklyvyb | Jkhc | $38.2 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Vfsspvlw | Blrs | $14.6 Bil | |
VTRS
| Viatris Inc | Trdcvffxz | Cxlwr | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hfwbqcz | Prms | $12.6 Bil | |
CTLT
| Catalent Inc | Mwxrkmw | Nqjnfw | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Kgtrqss | Gxxmm | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Jwrmrrbdz | Qsvc | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Zkzlgcfzw | Zzbqt | $3.6 Bil |